Comparison of different treatment schemes in 5-ALA interstitial photodynamic therapy for high-grade glioma in a preclinical model: An MRI study

Photodiagnosis Photodyn Ther. 2019 Mar:25:166-176. doi: 10.1016/j.pdpdt.2018.12.003. Epub 2018 Dec 10.

Abstract

Background: There is currently no therapy that prevents high-grade glioma recurrence. Thus, these primary brain tumors have unfavorable outcomes. Recently, 5-ALA photodynamic therapy (PDT) has been proposed to delay relapse and is highly expected to have potential synergistic effects with the current standard of care. However, PDT treatment delivery needs to be optimized by evaluating the impact of both the number of fractions and the light power used.

Objectives: Previous studies have reported MRI examination-based outcomes for PDT in glioblastoma. Our study aimed to compare MRI markers across different treatment schemes that use interstitial PDT in high-grade glioma in a preclinical model.

Materials and methods: Forty-eight "nude" rats were grafted with human U87 cells into the right putamen and subsequently submitted to interstitial PDT. The rats were randomized into six groups, including two different sham groups and four different treated groups (5 fractions at 5 mW or 30 mW and 2 fractions at 5 mW or 30 mW). After photosensitizer (PS) precursor (5-ALA) intake, an optical fiber was introduced into the tumor. Treatment effects were assessed with early high-field MRI to acquire T1 and T2 diffusion and perfusion images.

Results: There was no difference in the variation of the diffusion coefficient among the six groups (p = 0.0549, Kruskal-Wallis test). However, a significant difference was identified among the six groups in terms of variation in perfusion (p = 0.048, Kruskal-Wallis test), supporting a lesional effect in the treated groups. Additionally, the sham groups had significantly smaller edema volumes than were observed in the treated groups. Moreover, the 5-fraction group treated with 30 mW was associated with edema volumes that were significantly greater than those in the 5-fraction group treated with 5 mW (p = 0.019).

Conclusion: Based on observations of MRI data and considering treatment effects, the 5-fraction group treated at 5 mW was not significantly different from the other treated groups in terms of cell deaths, characterized by diffusion imaging, or necrosis level. However, the significantly lower level of edema observed in this group indicated that this treatment scheme had limited toxicity.

Keywords: 5-ALA; Glioblastoma; High-grade glioma; MRI; Magnetic resonance imaging; PDT; Photodynamic therapy; PpIX.

MeSH terms

  • Aminolevulinic Acid / administration & dosage
  • Aminolevulinic Acid / pharmacology*
  • Animals
  • Biomarkers, Tumor
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / drug therapy*
  • Cell Line, Tumor
  • Glioma / diagnostic imaging
  • Glioma / drug therapy*
  • Humans
  • Lasers, Semiconductor / therapeutic use
  • Magnetic Resonance Imaging
  • Photochemotherapy / methods*
  • Photosensitizing Agents / administration & dosage
  • Photosensitizing Agents / pharmacology*
  • Random Allocation
  • Rats
  • Rats, Nude

Substances

  • Biomarkers, Tumor
  • Photosensitizing Agents
  • Aminolevulinic Acid